MDBriefCase will be unavailable due to maintenance from Sunday, January 14 11PM to Monday, January 15 1AM ET.
Welcome
MDBriefCase Group Inc. (MDBC), Canada’s leading provider of online continuing medical education and professional development for healthcare providers, is excited to announce the acquisition of OncologyEducation. OncologyEducation is a comprehensive online platform providing evidence-based oncology content, developed and authored by a leading, international faculty of oncology professionals.
“We are excited to add OncologyEducation to our family of online educational resources for healthcare professionals,” said Jason Flowerday, CEO of MDBC. “This acquisition aligns with our commitment to investing in critical therapeutic areas to provide our worldwide members with the latest scientific resources for informed healthcare decision-making. Together, MDBriefCase and OncologyEducation serves to provide the pharmaceutical and biotech sectors with improved access and reach to innovative medical education opportunities and programming.”
“OncologyEducation was founded on the principle of improving patient care by providing oncology professionals worldwide with the latest oncology information resources,” said Dr. Berry, co-founder of OncologyEducation. “We are a global organization that has grown to have strong credibility among healthcare professionals around the world, and we are confident that MDBriefCase’s track record of global success can further expand the reach and impact of quality oncology education through its innovative offerings.”
Since 2001, MDBC has delivered interactive, peer-reviewed, and evidence-based programs to more that 250,000 members around the world. Committed to enhancing quality of care and healthcare decision-making, MDBC offers educational resources for healthcare professionals in Canada, Australia, the Middle East, and Europe. Through this critical acquisition, MDBC can provide a growing number of members with access to the most current oncology information and resources available.
Delivering educational content to healthcare professionals in over twenty countries, MDBC is proud to welcome OncologyEducation into the fold during a time that brings even more opportunity for innovation in health education.
For further information: Megan Chapman, Director of Marketing, MDBriefCase Group Inc., T: 416-488-5500 x292, E: mchapman@mdbriefcase.com
About MDBriefCase Group Inc.
MDBriefCase Group Inc. specializes in developing online, accredited and unaccredited continuing professional development for healthcare professionals. The company partners with prestigious regional and international medical associations to ensure its innovative education programs reflect the local experiences of healthcare professionals around the world. Its programs are peer-reviewed by clinical specialists to ensure balance and applicability to practice. Over 250,000 healthcare professionals have access to the latest evidence-based information and guidelines to improve local patient care. For more information, visit MDBC’s website at: www.mdbriefcase.com
About OncologyEducation
OncologyEducation is led by Dr. Scott Berry, a medical oncologist, Professor and Head of the Queen’s University Department of Oncology. Dr. Berry is the Medical Director at the Cancer Centre of Southeastern Ontario at the Kingston Health Sciences Centre. Dr. Berry co-found OncologyEducation with the goal to provide rich, timely and unbiased physician-authored resources to thousands of oncology professionals worldwide. OncologyEducation connects a global community that includes thousands of physicians, specialists, nurses, pharmacists, students, residents and researchers. Its mission is to improve patient care through education, in particular knowledge resources, innovative practices and networking opportunities. For more information, visit OncologyEducation’s website at: www.oncologyeducation.com
About Persistence Capital Partners
Persistence Capital Partners is Canada’s leading private equity fund exclusively focused on high-growth opportunities in the healthcare field. With deep healthcare industry expertise, PCP aims to create significant long-term capital appreciation for its investors by identifying and developing attractive investment opportunities in the Canadian healthcare market. PCP has offices in Montreal, Quebec, and Toronto, Ontario. www.persistencecapital.com
199 Bay Street #4000, Toronto,
ON M5L 1A9
In submitting your work (the “Work”) for potential posting on the MDBriefCase Healthcare Leadership Lab website (the “Website”), you (“You”) expressly agree to the following:
Review: MDBriefCase is pleased to consider the publication of Your Work on the Website. The suitability of the Work for posting shall be determined by MDBRiefCase at its sole discretion. Nothing herein shall obligate MDBriefcase to post or otherwise publish the Work, or the maintain its posting in future.
Editing; Identification: MDBriefcase shall have the right to edit the Work to conform to our standards of style, technological requirements, language usage, grammar and punctuation, provided that the meaning of the Work is not materially altered. If posted, You will be identified as the author of the Work, or co-author if applicable.
Grant of Rights: As a condition of publication and for no monetary compensation, You hereby grant to MDBriefCase the following rights to the Work in any and all media whether now existing or hereafter developed, including print and electronic/digital formats: (1) the exclusive right of first publication worldwide; (2) the perpetual non-exclusive worldwide right to publish, reproduce, distribute, sell, adapt, perform, display, sublicense, and create derivative works, alone or in conjunction with other materials; (3) the perpetual non-exclusive worldwide right to use the Work, or any part thereof, in any other publication produced by MDBriefCase and/or on MDBriefCase’s website; and (4) the perpetual non-exclusive worldwide right to use the Work to promote and publicize MDBriefCase or its publications. The grant of rights survives termination or expiration of this Agreement.
Warranty: You warrant that the Work is original with You and that it is not subject to any third party copyright; that You have authority to grant the rights in this Agreement; that publication of the Work will not libel anyone or infringe on or invade the rights of others; that You have full power and authority to enter into this Agreement; that the Work has not been published elsewhere in whole or in part; and that You have obtained permission from the copyright owner consistent with this Agreement for any third party copyrighted material in the Work. This warranty survives termination or expiration of this Agreement.
Thank you for your interest in writing an article for the MDBriefCase Healthcare Leadership Lab website.
The Healthcare Leadership Lab welcomes submissions on all topics relevant to leaders in healthcare. Our topics include Leading in Healthcare, Leadership Lessons from COVID-19 and others. We prioritize stories that provide leadership advice to executives and managers in healthcare companies, offer actionable strategies for executing successful projects, and provide interesting angles on current healthcare topics. Submissions must be original work of the authors and unpublished. When submitting, authors represent that they have included no material that is in violation of the rights of any other person or entity.
Articles must be educational and non-promotional. If they mention the author’s company or any of the company’s products or services by name within the text, such mention should be very limited and used for reference only, not for promotion. (For example, an author might cite a survey conducted by his company but not describe his company’s product as a solution to a business problem.) Articles will be edited for clarity, style and brevity. The final headline is determined by the editor.
Guest articles for the MDBriefCase Healthcare Leadership Lab may run between 500 and 1000 words.
MDBriefCase reserves the right to accept or reject any submission and the right to condition acceptance upon revision of material to conform to its criteria.
There is no payment for contributed articles. However, MDBriefCase will give the author a byline. Authors are invited to link to the article on personal websites, corporate websites and social media platforms.
Each author understands and agrees that any submission accepted for posting is provided subject to MDBriefCase’s Author Agreement.
